Screening and Evaluation of Potential Efflux Pump Inhibitors with a Seaweed Compound Diphenylmethane-Scaffold against Drug-Resistant Escherichia coli

Drug-resistant efflux pumps play a crucial role in bacterial antibiotic resistance. In this study, potential efflux pump inhibitors (EPIs) with a diphenylmethane scaffold were screened and evaluated against drug-resistant Escherichia coli. Twenty-four compounds were docked against the drug-binding s...

Full description

Saved in:
Bibliographic Details
Published inAntibiotics (Basel) Vol. 13; no. 7; p. 628
Main Authors Lu, Wen-Jung, Lian, Yu-Wei, Chang, Chun-Ju, Lin, Hsuan-Ju, Huang, Chian-Yun, Hsu, Pang-Hung, Lin, Hong-Ting
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Drug-resistant efflux pumps play a crucial role in bacterial antibiotic resistance. In this study, potential efflux pump inhibitors (EPIs) with a diphenylmethane scaffold were screened and evaluated against drug-resistant Escherichia coli. Twenty-four compounds were docked against the drug-binding site of E. coli multidrug transporter AcrB, and 2,2-diphenylethanol (DPE), di-p-tolyl-methanol (DPT), and 4-(benzylphenyl) acetonitrile (BPA) were screened for their highest binding free energy. The modulation assay was further used for EPI evaluation, revealing that DPE, DPT, and BPA could reduce the drug IC50 value in E. coli strains overexpressing AcrB, indicating their modulation activity. Only DPE and BPA enhanced intracellular dye accumulation and inhibited the efflux of ethidium bromide and erythromycin. In addition, DPE and BPA showed an elevated post-antibiotic effect on drug-resistant E. coli, and they did not damage the permeability of the bacterial outer membrane. The cell toxicity test showed that DPE and BPA had limited human-cell toxicity. Therefore, DPE and BPA demonstrate efflux pump inhibitory activity, and they should be further explored as potential enhancers to improve the effectiveness of existing antibiotics against drug-resistant E. coli.
AbstractList Drug-resistant efflux pumps play a crucial role in bacterial antibiotic resistance. In this study, potential efflux pump inhibitors (EPIs) with a diphenylmethane scaffold were screened and evaluated against drug-resistant Escherichia coli. Twenty-four compounds were docked against the drug-binding site of E. coli multidrug transporter AcrB, and 2,2-diphenylethanol (DPE), di-p-tolyl-methanol (DPT), and 4-(benzylphenyl) acetonitrile (BPA) were screened for their highest binding free energy. The modulation assay was further used for EPI evaluation, revealing that DPE, DPT, and BPA could reduce the drug IC50 value in E. coli strains overexpressing AcrB, indicating their modulation activity. Only DPE and BPA enhanced intracellular dye accumulation and inhibited the efflux of ethidium bromide and erythromycin. In addition, DPE and BPA showed an elevated post-antibiotic effect on drug-resistant E. coli, and they did not damage the permeability of the bacterial outer membrane. The cell toxicity test showed that DPE and BPA had limited human-cell toxicity. Therefore, DPE and BPA demonstrate efflux pump inhibitory activity, and they should be further explored as potential enhancers to improve the effectiveness of existing antibiotics against drug-resistant E. coli.
Drug-resistant efflux pumps play a crucial role in bacterial antibiotic resistance. In this study, potential efflux pump inhibitors (EPIs) with a diphenylmethane scaffold were screened and evaluated against drug-resistant Escherichia coli. Twenty-four compounds were docked against the drug-binding site of E. coli multidrug transporter AcrB, and 2,2-diphenylethanol (DPE), di-p-tolyl-methanol (DPT), and 4-(benzylphenyl) acetonitrile (BPA) were screened for their highest binding free energy. The modulation assay was further used for EPI evaluation, revealing that DPE, DPT, and BPA could reduce the drug IC[sub.50] value in E. coli strains overexpressing AcrB, indicating their modulation activity. Only DPE and BPA enhanced intracellular dye accumulation and inhibited the efflux of ethidium bromide and erythromycin. In addition, DPE and BPA showed an elevated post-antibiotic effect on drug-resistant E. coli, and they did not damage the permeability of the bacterial outer membrane. The cell toxicity test showed that DPE and BPA had limited human-cell toxicity. Therefore, DPE and BPA demonstrate efflux pump inhibitory activity, and they should be further explored as potential enhancers to improve the effectiveness of existing antibiotics against drug-resistant E. coli.
Drug-resistant efflux pumps play a crucial role in bacterial antibiotic resistance. In this study, potential efflux pump inhibitors (EPIs) with a diphenylmethane scaffold were screened and evaluated against drug-resistant . Twenty-four compounds were docked against the drug-binding site of multidrug transporter AcrB, and 2,2-diphenylethanol (DPE), di- -tolyl-methanol (DPT), and 4-(benzylphenyl) acetonitrile (BPA) were screened for their highest binding free energy. The modulation assay was further used for EPI evaluation, revealing that DPE, DPT, and BPA could reduce the drug IC value in strains overexpressing AcrB, indicating their modulation activity. Only DPE and BPA enhanced intracellular dye accumulation and inhibited the efflux of ethidium bromide and erythromycin. In addition, DPE and BPA showed an elevated post-antibiotic effect on drug-resistant , and they did not damage the permeability of the bacterial outer membrane. The cell toxicity test showed that DPE and BPA had limited human-cell toxicity. Therefore, DPE and BPA demonstrate efflux pump inhibitory activity, and they should be further explored as potential enhancers to improve the effectiveness of existing antibiotics against drug-resistant .
Drug-resistant efflux pumps play a crucial role in bacterial antibiotic resistance. In this study, potential efflux pump inhibitors (EPIs) with a diphenylmethane scaffold were screened and evaluated against drug-resistant Escherichia coli. Twenty-four compounds were docked against the drug-binding site of E. coli multidrug transporter AcrB, and 2,2-diphenylethanol (DPE), di-p-tolyl-methanol (DPT), and 4-(benzylphenyl) acetonitrile (BPA) were screened for their highest binding free energy. The modulation assay was further used for EPI evaluation, revealing that DPE, DPT, and BPA could reduce the drug IC50 value in E. coli strains overexpressing AcrB, indicating their modulation activity. Only DPE and BPA enhanced intracellular dye accumulation and inhibited the efflux of ethidium bromide and erythromycin. In addition, DPE and BPA showed an elevated post-antibiotic effect on drug-resistant E. coli, and they did not damage the permeability of the bacterial outer membrane. The cell toxicity test showed that DPE and BPA had limited human-cell toxicity. Therefore, DPE and BPA demonstrate efflux pump inhibitory activity, and they should be further explored as potential enhancers to improve the effectiveness of existing antibiotics against drug-resistant E. coli.Drug-resistant efflux pumps play a crucial role in bacterial antibiotic resistance. In this study, potential efflux pump inhibitors (EPIs) with a diphenylmethane scaffold were screened and evaluated against drug-resistant Escherichia coli. Twenty-four compounds were docked against the drug-binding site of E. coli multidrug transporter AcrB, and 2,2-diphenylethanol (DPE), di-p-tolyl-methanol (DPT), and 4-(benzylphenyl) acetonitrile (BPA) were screened for their highest binding free energy. The modulation assay was further used for EPI evaluation, revealing that DPE, DPT, and BPA could reduce the drug IC50 value in E. coli strains overexpressing AcrB, indicating their modulation activity. Only DPE and BPA enhanced intracellular dye accumulation and inhibited the efflux of ethidium bromide and erythromycin. In addition, DPE and BPA showed an elevated post-antibiotic effect on drug-resistant E. coli, and they did not damage the permeability of the bacterial outer membrane. The cell toxicity test showed that DPE and BPA had limited human-cell toxicity. Therefore, DPE and BPA demonstrate efflux pump inhibitory activity, and they should be further explored as potential enhancers to improve the effectiveness of existing antibiotics against drug-resistant E. coli.
Audience Academic
Author Lu, Wen-Jung
Lin, Hsuan-Ju
Huang, Chian-Yun
Hsu, Pang-Hung
Chang, Chun-Ju
Lin, Hong-Ting
Lian, Yu-Wei
Author_xml – sequence: 1
  givenname: Wen-Jung
  surname: Lu
  fullname: Lu, Wen-Jung
– sequence: 2
  givenname: Yu-Wei
  surname: Lian
  fullname: Lian, Yu-Wei
– sequence: 3
  givenname: Chun-Ju
  surname: Chang
  fullname: Chang, Chun-Ju
– sequence: 4
  givenname: Hsuan-Ju
  surname: Lin
  fullname: Lin, Hsuan-Ju
– sequence: 5
  givenname: Chian-Yun
  surname: Huang
  fullname: Huang, Chian-Yun
– sequence: 6
  givenname: Pang-Hung
  orcidid: 0000-0001-6873-6434
  surname: Hsu
  fullname: Hsu, Pang-Hung
– sequence: 7
  givenname: Hong-Ting
  orcidid: 0000-0002-8737-208X
  surname: Lin
  fullname: Lin, Hong-Ting
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39061310$$D View this record in MEDLINE/PubMed
BookMark eNp9UltrFDEUHqRia-0vECTgiy9Tk8lcMo-lXXWhYHH1OZzJnOxkmUnWJNPaH-L_NdttvZRiQkg4fJecw_cyO7DOYpa9ZvSU85a-BxtNZ1w0KjBOG1oX4ll2VNCmzWsuioO_3ofZSQgbmlbLuKDiRXaYFGrGGT3Kfq6UR7TGrgnYniyuYZwhGmeJ0-TKRUw-MJKF1uP8g1zN05Ys7ZCso_OB3Jg4ECArhBvEnpy7aevmJHNhtgPa23HCOIDFfKVAazf2BNZgbIjkws_r_AsGE2LqhCyCGtAbNRggyo3mVfZcwxjw5P4-zr59WHw9_5Rffv64PD-7zFXFWMwrWqgGBcOKdZQBtg1FUAIpK3hV9JXCoippBZ0QTY-qEpS1KPoOGJRNLTp-nC33ur2Djdx6M4G_lQ6MvCs4v5bg04xHlC1HXTZVXQKqEkUHtAbN64qzQnDWQdJ6t9faevd9xhDlZILCcUwDcHOQnIr06bLmPEHfPoJu3Oxt6nSHKhtKGRN_UGtI_sZqFz2onag8E7RoaTpVQp0-gUq7x8moFBptUv0fwpt787mbsP_d9UMmEqDdA5R3IXjUUpl4l4mkbEbJqNxFUD4RwcTlj7gP8v9j_QL8BuJN
CitedBy_id crossref_primary_10_3389_fmicb_2025_1527546
Cites_doi 10.3390/antibiotics12010180
10.1038/472032a
10.3389/fmicb.2019.02762
10.3390/ijms19041000
10.1128/spectrum.03324-22
10.1128/AAC.42.7.1778
10.1093/jac/dkh275
10.7717/peerj.3168
10.1128/AAC.37.1.128
10.1021/acs.jcim.1c00203
10.1128/AAC.00326-21
10.1046/j.1365-2672.2000.00971.x
10.4238/gmr16039777
10.3389/fmicb.2015.00421
10.2174/1871526520999200905121220
10.1021/acsinfecdis.1c00281
10.1038/s41467-021-24151-3
10.3389/fphar.2022.953982
10.1080/00498250310001657568
10.1093/jac/29.2.137
10.1155/2019/1836982
10.1111/j.1574-6976.2011.00290.x
10.3389/fmicb.2019.02153
10.3390/antibiotics11040497
10.1021/acs.jpcb.3c05845
10.3390/antibiotics10111378
10.1128/AAC.34.1.102
10.1093/nar/28.1.235
10.1021/acs.jmedchem.7b00215
10.1007/s11101-015-9436-y
10.1002/jcc.20084
10.1128/AAC.01866-13
10.3390/antibiotics9100639
10.1021/acs.jpcb.5b11942
10.1016/B978-0-12-418697-2.00001-5
10.1016/j.resmic.2018.05.005
10.1038/s41467-020-19397-2
10.1128/spectrum.04876-22
10.1002/jcc.21334
10.1073/pnas.1114944109
ContentType Journal Article
Copyright COPYRIGHT 2024 MDPI AG
2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: COPYRIGHT 2024 MDPI AG
– notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
NPM
7QL
7T7
8FD
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
GNUQQ
HCIFZ
LK8
M7P
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
7X8
DOA
DOI 10.3390/antibiotics13070628
DatabaseName CrossRef
PubMed
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Engineering Research Database
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


PubMed
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2079-6382
ExternalDocumentID oai_doaj_org_article_93ef47564aec4e8ba06af365312831ba
A802900295
39061310
10_3390_antibiotics13070628
Genre Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GrantInformation_xml – fundername: Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan
  grantid: NTOU-RD-AA-2021-1-02018
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAFWJ
AAHBH
AAYXX
ADBBV
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
CITATION
ECGQY
GROUPED_DOAJ
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M48
M7P
MODMG
M~E
OK1
OZF
PGMZT
PHGZM
PHGZT
PIMPY
PROAC
RPM
NPM
PMFND
7QL
7T7
8FD
ABUWG
AZQEC
C1K
DWQXO
FR3
GNUQQ
P64
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
7X8
PUEGO
ID FETCH-LOGICAL-c511t-502c7e81e51b01ae970eac8e012352d5ce25405ab887dec58019e8dba1a4768b3
IEDL.DBID M48
ISSN 2079-6382
IngestDate Wed Aug 27 01:21:43 EDT 2025
Fri Jul 11 04:17:47 EDT 2025
Fri Jul 25 12:10:28 EDT 2025
Tue Jun 17 22:06:55 EDT 2025
Tue Jun 10 21:03:39 EDT 2025
Thu Jan 02 22:29:11 EST 2025
Thu Apr 24 23:04:45 EDT 2025
Tue Jul 01 02:10:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords drug transporters
multidrug resistance
drug efflux
molecular docking
efflux pump inhibitors
Language English
License https://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c511t-502c7e81e51b01ae970eac8e012352d5ce25405ab887dec58019e8dba1a4768b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8737-208X
0000-0001-6873-6434
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/antibiotics13070628
PMID 39061310
PQID 3084700118
PQPubID 2032437
ParticipantIDs doaj_primary_oai_doaj_org_article_93ef47564aec4e8ba06af365312831ba
proquest_miscellaneous_3085114633
proquest_journals_3084700118
gale_infotracmisc_A802900295
gale_infotracacademiconefile_A802900295
pubmed_primary_39061310
crossref_citationtrail_10_3390_antibiotics13070628
crossref_primary_10_3390_antibiotics13070628
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-07-01
PublicationDateYYYYMMDD 2024-07-01
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Antibiotics (Basel)
PublicationTitleAlternate Antibiotics (Basel)
PublicationYear 2024
Publisher MDPI AG
Publisher_xml – name: MDPI AG
References Hanberger (ref_26) 1990; 34
Nikaido (ref_4) 2012; 36
ref_14
ref_13
Cooper (ref_3) 2011; 472
Lu (ref_37) 2021; 65
ref_10
Queiroz (ref_29) 2017; 16
Prasch (ref_21) 2015; 14
Stubbings (ref_42) 2004; 54
ref_18
Chandal (ref_30) 2023; 11
ref_16
Machado (ref_24) 2017; 5
Soothill (ref_38) 1992; 29
ref_15
Pettersen (ref_34) 2004; 25
Lu (ref_17) 2019; 2019
Khoshnood (ref_22) 2021; 21
Eberhardt (ref_33) 2021; 61
Helander (ref_43) 2000; 88
Neyfakh (ref_6) 1993; 37
Eicher (ref_35) 2012; 109
Machado (ref_39) 2011; 25
Hewitt (ref_28) 2004; 34
Schillaci (ref_11) 2017; 60
Zwama (ref_7) 2018; 169
Morita (ref_31) 1998; 42
Trott (ref_32) 2010; 31
Bera (ref_8) 2024; 128
Naghavi (ref_2) 2022; 6
Zuo (ref_12) 2016; 120
ref_41
Tam (ref_20) 2021; 12
ref_40
ref_1
Reading (ref_19) 2020; 11
ref_27
ref_9
Tambat (ref_23) 2022; 8
Berman (ref_36) 2000; 28
ref_5
Opperman (ref_25) 2014; 58
References_xml – ident: ref_9
  doi: 10.3390/antibiotics12010180
– volume: 472
  start-page: 32
  year: 2011
  ident: ref_3
  article-title: Fix the antibiotics pipeline
  publication-title: Nature
  doi: 10.1038/472032a
– ident: ref_5
  doi: 10.3389/fmicb.2019.02762
– ident: ref_40
  doi: 10.3390/ijms19041000
– ident: ref_14
  doi: 10.1128/spectrum.03324-22
– volume: 42
  start-page: 1778
  year: 1998
  ident: ref_31
  article-title: NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.42.7.1778
– volume: 54
  start-page: 139
  year: 2004
  ident: ref_42
  article-title: Assessment of a microplate method for determining the post-antibiotic effect in Staphylococcus aureus and Escherichia coli
  publication-title: J. Antimicrob. Chemoth
  doi: 10.1093/jac/dkh275
– volume: 5
  start-page: e3168
  year: 2017
  ident: ref_24
  article-title: Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli
  publication-title: Peerj
  doi: 10.7717/peerj.3168
– volume: 37
  start-page: 128
  year: 1993
  ident: ref_6
  article-title: Fluoroquinolone Resistance Protein Nora of Staphylococcus aureus Is a Multidrug Efflux Transporter
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.37.1.128
– volume: 61
  start-page: 3891
  year: 2021
  ident: ref_33
  article-title: AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/acs.jcim.1c00203
– volume: 65
  start-page: 10-1128
  year: 2021
  ident: ref_37
  article-title: A Novel Cooperative Metallo-β-Lactamase Fold Metallohydrolase from Pathogen Exhibits β-Lactam Antibiotic-Degrading Activities
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.00326-21
– volume: 88
  start-page: 213
  year: 2000
  ident: ref_43
  article-title: Fluorometric assessment of Gram-negative bacterial permeabilization
  publication-title: J. Appl. Microbiol.
  doi: 10.1046/j.1365-2672.2000.00971.x
– volume: 16
  start-page: gmr16039777
  year: 2017
  ident: ref_29
  article-title: Cytotoxic and genotoxic potential of geraniol in peripheral blood mononuclear cells and human hepatoma cell line (HepG2)
  publication-title: Genet. Mol. Res.
  doi: 10.4238/gmr16039777
– ident: ref_15
  doi: 10.3389/fmicb.2015.00421
– volume: 21
  start-page: 564
  year: 2021
  ident: ref_22
  article-title: Involvement of the AcrAB Efflux Pump in Ciprofloxacin Resistance in Clinical Klebsiella pneumoniae Isolates
  publication-title: Infect. Disord. Drug Targets
  doi: 10.2174/1871526520999200905121220
– volume: 8
  start-page: 255
  year: 2022
  ident: ref_23
  article-title: A Microbe-Derived Efflux Pump Inhibitor of the Resistance-Nodulation-Cell Division Protein Restores Antibiotic Susceptibility in Escherichia coli and Pseudomonas aeruginosa
  publication-title: Acs Infect. Dis.
  doi: 10.1021/acsinfecdis.1c00281
– volume: 12
  start-page: 3889
  year: 2021
  ident: ref_20
  article-title: Allosteric drug transport mechanism of multidrug transporter AcrB
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-24151-3
– ident: ref_13
  doi: 10.3389/fphar.2022.953982
– volume: 34
  start-page: 243
  year: 2004
  ident: ref_28
  article-title: Phase I and II enzyme characterization of two sources of HepG2 cell lines
  publication-title: Xenobiotica
  doi: 10.1080/00498250310001657568
– ident: ref_1
– volume: 29
  start-page: 137
  year: 1992
  ident: ref_38
  article-title: The IC50—An Exactly Defined Measure of Antibiotic-Sensitivity
  publication-title: J. Antimicrob. Chemother.
  doi: 10.1093/jac/29.2.137
– volume: 2019
  start-page: 1836982
  year: 2019
  ident: ref_17
  article-title: Brown and Red Seaweeds Serve as Potential Efflux Pump Inhibitors for Drug-Resistant
  publication-title: Evid.-Based Compl. Alt.
  doi: 10.1155/2019/1836982
– volume: 36
  start-page: 340
  year: 2012
  ident: ref_4
  article-title: Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
  publication-title: Fems Microbiol. Rev.
  doi: 10.1111/j.1574-6976.2011.00290.x
– ident: ref_27
  doi: 10.3389/fmicb.2019.02153
– ident: ref_10
  doi: 10.3390/antibiotics11040497
– volume: 128
  start-page: 648
  year: 2024
  ident: ref_8
  article-title: Machine learning-guided discovery of AcrB and MexB efflux pump inhibitors
  publication-title: J. Phys. Chem. B
  doi: 10.1021/acs.jpcb.3c05845
– ident: ref_18
  doi: 10.3390/antibiotics10111378
– volume: 34
  start-page: 102
  year: 1990
  ident: ref_26
  article-title: Postantibiotic Effect of Beta-Lactam Antibiotics on Escherichia coli Evaluated by Bioluminescence Assay of Bacterial Atp
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.34.1.102
– volume: 28
  start-page: 235
  year: 2000
  ident: ref_36
  article-title: The Protein Data Bank
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/28.1.235
– volume: 60
  start-page: 8268
  year: 2017
  ident: ref_11
  article-title: Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.7b00215
– volume: 14
  start-page: 961
  year: 2015
  ident: ref_21
  article-title: Plant derived inhibitors of bacterial efflux pumps: An update
  publication-title: Phytochem. Rev.
  doi: 10.1007/s11101-015-9436-y
– volume: 25
  start-page: 1605
  year: 2004
  ident: ref_34
  article-title: UCSF chimera—A visualization system for exploratory research and analysis
  publication-title: J. Comput. Chem.
  doi: 10.1002/jcc.20084
– volume: 58
  start-page: 722
  year: 2014
  ident: ref_25
  article-title: Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01866-13
– ident: ref_41
  doi: 10.3390/antibiotics9100639
– volume: 6
  start-page: 629
  year: 2022
  ident: ref_2
  article-title: Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis
  publication-title: Lancet
– volume: 120
  start-page: 2145
  year: 2016
  ident: ref_12
  article-title: Insights into the inhibitory mechanism of D13-9001 to the multidrug transporter AcrB through molecular dynamics simulations
  publication-title: J. Phys. Chem. B
  doi: 10.1021/acs.jpcb.5b11942
– ident: ref_16
  doi: 10.1016/B978-0-12-418697-2.00001-5
– volume: 25
  start-page: 769
  year: 2011
  ident: ref_39
  article-title: Biological activity of twenty-three hydantoin derivatives on intrinsic efflux pump system of Salmonella enterica serovar Enteritidis NCTC 13349
  publication-title: In Vivo
– volume: 169
  start-page: 372
  year: 2018
  ident: ref_7
  article-title: Molecular mechanisms of AcrB-mediated multidrug export
  publication-title: Res. Microbiol.
  doi: 10.1016/j.resmic.2018.05.005
– volume: 11
  start-page: 5565
  year: 2020
  ident: ref_19
  article-title: Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-19397-2
– volume: 11
  start-page: e04876-22
  year: 2023
  ident: ref_30
  article-title: Efflux pump inhibitory potential of indole derivatives as an arsenal against overexpressing Staphylococcus aureus
  publication-title: Microbiol. Spectr.
  doi: 10.1128/spectrum.04876-22
– volume: 31
  start-page: 455
  year: 2010
  ident: ref_32
  article-title: Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
  publication-title: J. Comput. Chem.
  doi: 10.1002/jcc.21334
– volume: 109
  start-page: 5687
  year: 2012
  ident: ref_35
  article-title: Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1114944109
SSID ssj0000913808
Score 2.2993755
Snippet Drug-resistant efflux pumps play a crucial role in bacterial antibiotic resistance. In this study, potential efflux pump inhibitors (EPIs) with a...
SourceID doaj
proquest
gale
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
StartPage 628
SubjectTerms Acetonitrile
Algae
Antibiotic resistance
Antibiotics
Bacteria
Binding sites
Cytotoxicity
Damage accumulation
Diphenyl methane
Drug dosages
drug efflux
Drug resistance
Drug resistance in microorganisms
drug transporters
E coli
Efflux
efflux pump inhibitors
Erythromycin
Escherichia coli
Ethidium bromide
Free energy
Gram-negative bacteria
Inhibitors
Membrane permeability
Modulation
molecular docking
multidrug resistance
Penicillin G
Pharmaceutical industry
Scaffolds
Seaweeds
Tetracycline
Tetracyclines
Toxicity
Toxicity testing
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQb0ILMhIql42axI-Nj4VuVZBAK7aVeotsZ1wirRLUzardH8L_ZSZJ0y0guHBN7MiTGc98k4y_Yewtbj5RBpXEudMQy2muYyNtiANGGw9eJJmjRPHzF31yJj-dq_OtVl9UE9bTA_cv7sAICHKqtLTgJeTOJtoGodF0MDCmroNGGPO2kqnOB5tU5Ene0wwJzOsPcJ2VqxriPk7JzjX1X98KRR1j_-9--Re02UWd44fswQAX-WG_zEfsHtSP2f6855veTPjp7fGp1YTv8_ktE_XmCfux8FRWg9GJ27rks5HZmzeBz5uWKoXw6bMQlutrPkfN8o_1NxSAWvBw-kTLLV-AvcIQx8lzUA8mflRRXdhmSc2nbQ3xwtsQmmXJ7YWtEG3yo8v1RfwVVgRN65bPVmQYFRVVc1xZ9ZSdHc9OP5zEQx-G2CMca2OVZH4KeQoqdUlqwUwTdNc5dOdss1J5yAj3WYcOqwSvMOgZyEtnUysxm3HiGdupmxpeMC4cAqBSGdCulDoYY6UsvdAyGAwawkQsu1FJ4QeScuqVsSwwWSE9Fn_QY8Qm46TvPUfH34e_J12PQ4lgu7uAZlcMZlf8y-wi9o4spSA3gAv0djjNgGISoVZxmCeZoV-eKmJ7d0bi9vV3b9_YWjG4j1UhEgQNHT1fxN6Mt2kmlcTV0Ky7MYqOlAsRsee9jY4ioeQI09Lk5f8QdZfdzxDJ9TXKe2ynvVzDK0RirXvdbbqfKrcz5g
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELVge-GC-CZQkJFQuWzUJHay9gm1NFVBooq6rdRbZDv2EmmVlE1WsD-E_8tMks1SQL0mTmRrxm-e7fEbQt7D5GOFiwNf6MT6fCYSX3LlfAfRxljDgkjjQvHreXJ2xb9cx9fDhlszpFVuMbED6qI2uEd-yALA0U6x7OPNdx-rRuHp6lBC4z7ZAwgWYkL2jtPz7GLcZUHVSxGIXm6Iwfr-EPpb6rJGDeQQ_T3BOux_hKROuf9ffP6LdXbR5_QReTjQRnrU2_kxuWerJ-Qg63WnN1N6ubtG1UzpAc12itSbp-TX3GB6DUQpqqqCpqPCN60dzeoWM4bg76lzy_VPmoGF6efqGwwAS_FQ3Kqlis6t-gGhjiKCYC0melJifthmiUWoVWX9uVHO1cuCqoUqgXXSk9V64V_YBilq1dK0QQcpMbmaQs_KZ-TqNL38dOYP9Rh8A7Ss9eMgMjMrQhuHOgiVlbMAYFvY7r5tVMTGRsj_lAbgKqyJIfhJKwqtQsVhVaPZczKp6sq-JJRpIEJFLG2iC544KRXnhWEJdxKCB5MeibYmyc0gVo41M5Y5LFrQjvl_7OiR6fjRTa_VcXfzY7T12BSFtrsH9WqRD_M2l8w6PosTrqzhVmgVJMqxBJALeFmolUc-oKfkCAfQQaOGWw0wTBTWyo9EEEk8-ow9sn-rJUxjc_v11tfyAUaafOf0Hnk3vsYvMTWusvW6axPj1XLGPPKi99FxSDByoGth8Orun78mDyLgan0W8j6ZtKu1fQNcq9Vvhwn1G3kTLKg
  priority: 102
  providerName: ProQuest
Title Screening and Evaluation of Potential Efflux Pump Inhibitors with a Seaweed Compound Diphenylmethane-Scaffold against Drug-Resistant Escherichia coli
URI https://www.ncbi.nlm.nih.gov/pubmed/39061310
https://www.proquest.com/docview/3084700118
https://www.proquest.com/docview/3085114633
https://doaj.org/article/93ef47564aec4e8ba06af365312831ba
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKe-GCeBMoKyOhctlAEjsPHxBqaaqC1GrV7Uq9RbZjbyNFCexmRfeH8H-ZSbKpFgoS18SJ7MzrG2f8DSFvwfhYbkPPTVRkXB4nkSu4tK6FaKONZl6gMFE8O49OZ_zrVXi1QzZdUfsPuLwztcN-UrNF-f7m-_oTGPxHzDghZf8AUyhUUSOtsY8qHAXJPbIHoSnGlgZnPd5vXbPwWdJ1qfNi4YLuBR0T0d_esxWtWlL_P133b4C0DUwnD8mDHlHSw04FHpEdUz0mB5OOkno9ppe3J6yWY3pAJ7dk1esn5OdUY-UNBDAqq5ymA_k3rS2d1A0WE8HbU2vL1Q2dgPDpl-oaFoBdeiju4lJJp0b-gChI0blgmyZ6XGDp2LrE_tSyMu5US2vrMqdyLgsApPR4sZq7F2aJ6LVqaLpE3Smw7prCzIqnZHaSXn4-dftWDa4GxNa4oRfo2CS-CX3l-dKI2AOPnpj2KG6Qh9oECA2lAp-WGx1CXBQmyZX0JYeER7FnZLeqK_OCUKYAI-WhMJHKeWSFkJznmkXcCogrTDgk2Igk0z2PObbTKDPIZ1CO2R1ydMh4eOhbR-Px7-FHKOthKHJwtxfqxTzrTToTzFgehxGXRnOTKOlF0rIInBpANl9Jh7xDTclQd2GCWvYHHmCZyLmVHSZeIPCvaOiQ_a2RYOF6-_ZG17KNgWTMA1zRMvg55M1wG5_EqrnK1Kt2TIinzhlzyPNOR4clwcoByfney__7Mq_I_QBgXVewvE92m8XKvAZY1qgR2TtKzycXo3ZbY9Qa3i-N9jsA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9NAEF2V9AAXxDeGAosE5RKra-_asQ8ItSRVQtsoalKpN7O73g2WIrvkQyU_hL_Bb2TGdlwKqLde4_XKm5l587yefUPIOwg-ntqAuZEKjSs6UejGQlrXQrbRRnPmK3xRPBmG_TPx5Tw43yK_NmdhsKxyg4klUKeFxj3yPc4AR0vFsk8X313sGoVfVzctNCq3ODLrS3hlW3wcdMG-733_sDf53HfrrgKuBnKxdAPm646JPBN4innSxB0G4BOZ8tSonwba-MhipILwS40OAMJjE6VKelIAN1cc5r1DtgUPmd8i2we94ei02dVBlc2IRZW8Eecx24P_J1NZgZrLHsZXiH3f_0iBZaeAf_PBXyy3zHaHD8j9mqbS_cqvHpItkz8iu6NK53rdppOrY1uLNt2loysF7PVj8nOssZwHsiKVeUp7jaI4LSwdFUusUILZe9bOVj_oCDyKDvJvsABs_UNxa5hKOjbyElIrRcTC3k-0m2E92nqGTa9lbtyxltYWs5TKqcyA5dLufDV1T80CKXG-pL0FOmSGxdwUnix7Qs5uxVJPSSsvcvOcUK6AeKVBbEKVitDGsRQi1TwUNoZkxWOH-BuTJLoWR8ceHbMEXpLQjsl_7OiQdnPTRaUNcvPwA7R1MxSFvcsfivk0qXEiibmxohOEQhotTKQkC6XlISAl8EBPSYd8QE9JEH7gAbWsT1HAMlHIK9mPmB_jp9bAITvXRgJs6OuXN76W1LC1SK6CzCFvm8t4J5bi5aZYlWMCPMrOuUOeVT7aLAlWDvTQYy9unvwNudufnBwnx4Ph0UtyzweeWFVA75DWcr4yr4DnLdXrOrgo-Xrb8fwbHyRpIQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2VVEK8IO4YCiwSlJdYWXttx35AqCWJGgqR1bRS38zuejdYiuySi0o-hJ_h65jxLRRQ3_oary1vZubM2fXsGULeQPDx1PjMDmWgba8fBnbkCWMbyDZKK85ciQvFL5Pg6Mz7dO6f75BfzVkYLKtsMLEE6rRQuEfe4wxwtFQs65m6LCIejD5cfLexgxR-aW3aaVQucqw3l7B8W74fD8DWb113NDz9eGTXHQZsBURjZfvMVX0dOtp3JHOEjvoMgCjU5QlSN_WVdpHRCAmhmGrlA5xHOkylcIQHPF1yeO4tstvHVVGH7B4OJ_FJu8ODipshCyupI84j1oP_KpNZgfrLDsZagD3g_0iHZdeAf3PDX4y3zHyje-RuTVnpQeVj98mOzh-Q_bjSvN506en2CNeyS_dpvFXD3jwkP6cKS3sgQ1KRp3TYqovTwtC4WGG1Ejx9aMx8_YPG4F10nH-DCWAbIIrbxFTQqRaXkGYpohf2gaKDDGvTNnNsgC1ybU-VMKaYp1TMRAaMlw4W65l9opdIj_MVHS7ROTMs7KbwZtkjcnYjlnpMOnmR66eEcgkkLPUjHcjUC0wUCc9LFQ88E0Hi4pFF3MYkiaqF0rFfxzyBBRPaMfmPHS3SbW-6qHRCrh9-iLZuh6LId_lDsZglNWYkEdfG6_uBJ7TydCgFC4ThAaAmcEJHCou8Q09JEIrgBZWoT1TANFHUKzkImRvhZ1ffIntXRgKEqKuXG19LaghbJtuAs8jr9jLeiWV5uS7W5Rgfj7VzbpEnlY-2U4KZA1V02LPrH_6K3IY4Tj6PJ8fPyR0XKGNVDL1HOqvFWr8AyreSL-vYouTrTYfzb8tnbVY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Screening+and+Evaluation+of+Potential+Efflux+Pump+Inhibitors+with+a+Seaweed+Compound+Diphenylmethane-Scaffold+against+Drug-Resistant+Escherichia+coli&rft.jtitle=Antibiotics+%28Basel%29&rft.au=Lu%2C+Wen-Jung&rft.au=Lian%2C+Yu-Wei&rft.au=Chang%2C+Chun-Ju&rft.au=Lin%2C+Hsuan-Ju&rft.date=2024-07-01&rft.issn=2079-6382&rft.eissn=2079-6382&rft.volume=13&rft.issue=7&rft.spage=628&rft_id=info:doi/10.3390%2Fantibiotics13070628&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_antibiotics13070628
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2079-6382&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2079-6382&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2079-6382&client=summon